Relmada Therapeutics Inc. (RLMD) Debt to Equity Ratio
Relmada Therapeutics Inc. (RLMD) debt-to-equity ratio history and balance sheet leverage. Analyze D/E ratio in Excel with MarketXLS.
Debt to Equity Ratio Data
| Period | Debt/Equity |
|---|---|
| 2013-08-31 | -2.47 |
| 2016-06-30 | 0.45 |
| 2017-06-30 | 0.94 |
| 2018-06-30 | -1.55 |
| 2019-06-30 | 0.34 |
| 2020-12-31 | 0.12 |
| 2021-12-31 | 0.07 |
| 2022-12-31 | 0.09 |
| 2023-12-31 | 0.14 |
| 2024-12-31 | 0.29 |
Get Relmada Therapeutics Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Debt_to_Equity_Ratio("RLMD", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | RLMD | $7.58 | +8.20% | 1.45M |
| 3 | ||||
| 4 | ||||
| 5 |